Abstract
Complexing agents showing strong complexation for Ca(II) and Al(HI) were formulated for preparing physicochemically stable parenteral phosphate solutions. From results of a model experiment, a correlation was confirmed between precipitation in the phosphate buffer solutions and the amount of Ca(II) and/or Al(III) remaining in the solution. To prevent precipitation in parenteral phosphate solutions, EDTA was found to be effective in the range pH 5 to pH 9, carboxylic acids such as citric acid and maleic acid in acidic to neutral solutions, and pyrophosphate and lysine HCl in alkaline solutions. Further, elimination of the metals causing the precipitation from phosphate buffer was studied using ion-exchange resin treatment, and the phosphate buffer treated under the proposed conditions was found to be satisfactorily applicable to parenteral buffer solutions.
- Received May 10, 1982.
- Accepted August 4, 1982.
- Copyright © Parenteral Drug Association. All rights reserved.
PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.
If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing.
Full issue PDFs are for PDA members only.
Note to pda.org users
The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.